Satoshi Watanabe Selected Research

Satoshi Watanabe Research Topics

Disease

61	Neoplasms (Cancer) 02/2024 - 01/2002
49	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 04/2010
23	Lung Neoplasms (Lung Cancer) 02/2024 - 09/2013
12	Myocardial Infarction 06/2019 - 08/2004
9	Inflammation (Inflammations) 11/2023 - 09/2006
9	Heart Failure 01/2023 - 10/2005
8	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2004
8	Infections 11/2023 - 10/2013
8	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 01/2013
8	Disease Progression 01/2023 - 01/2018
8	Pneumonia (Pneumonitis) 01/2023 - 10/2016
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2022 - 11/2013
6	Asthma (Bronchial Asthma) 01/2023 - 01/2015
6	Ganglion Cysts (Ganglion) 01/2013 - 07/2003
5	Idiopathic Pulmonary Fibrosis 03/2024 - 02/2018
5	Carcinoma (Carcinomatosis) 04/2022 - 01/2002
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2021 - 01/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 10/2006
4	Adenocarcinoma of Lung 02/2023 - 11/2013
4	Fibrosis (Cirrhosis) 06/2021 - 03/2005
4	Stomach Neoplasms (Stomach Cancer) 12/2017 - 01/2003
4	Osteonecrosis (Kienbock's Disease) 02/2016 - 09/2012
3	Brain Neoplasms (Brain Tumor) 04/2024 - 11/2019
3	Bronchiectasis 03/2024 - 01/2013
3	Cough 03/2024 - 08/2017
3	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 04/2015
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2024 - 02/2021
3	Wounds and Injuries (Trauma) 12/2023 - 01/2020
3	Sepsis (Septicemia) 11/2023 - 01/2018
3	Body Weight (Weight, Body) 11/2023 - 01/2016
3	Obstructive Sleep Apnea 09/2023 - 01/2023
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2017
3	Ulcerative Colitis 01/2023 - 01/2022
3	Vomiting 07/2021 - 09/2013
3	Bronchiolitis Obliterans 05/2021 - 02/2017
3	Dyspnea (Shortness of Breath) 05/2021 - 07/2016
3	Liver Diseases (Liver Disease) 01/2021 - 03/2018
3	Diarrhea 01/2021 - 07/2015
3	Respiratory Hypersensitivity 01/2020 - 01/2015
3	Melanoma (Melanoma, Malignant) 12/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

20	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2011
20	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2011
15	Proteins (Proteins, Gene)FDA Link 02/2023 - 12/2002
10	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2017
9	osimertinibIBA 12/2023 - 01/2019
9	PlatinumIBA 01/2023 - 12/2015
8	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 03/2016
8	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 08/2004
7	LigandsIBA 01/2023 - 01/2005
7	Gefitinib (Iressa)FDA Link 06/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2008
6	AfatinibIBA 01/2022 - 12/2015
5	AntibodiesIBA 02/2024 - 08/2016
5	Gemcitabine FDA Link 12/2023 - 06/2011
5	Pemetrexed (MTA)FDA Link 01/2023 - 01/2018
5	alectinibIBA 12/2022 - 01/2017
5	Bevacizumab (Avastin)FDA Link 12/2022 - 01/2019
5	Anaplastic Lymphoma KinaseIBA 12/2022 - 01/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2018 - 06/2011
4	NivolumabIBA 04/2024 - 10/2016
4	necitumumabIBA 12/2023 - 01/2019
4	B7-H1 AntigenIBA 02/2023 - 06/2018
4	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2019
4	pembrolizumabIBA 01/2023 - 01/2021
4	Therapeutic UsesIBA 01/2023 - 09/2008
4	AntigensIBA 11/2022 - 01/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2022 - 08/2004
4	SteroidsIBA 02/2021 - 06/2011
4	CytokinesIBA 03/2019 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2004
4	C-Reactive ProteinIBA 01/2018 - 09/2006
3	durvalumabIBA 04/2024 - 11/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 11/2013
3	Monoclonal AntibodiesIBA 01/2023 - 08/2004
3	CollagenIBA 11/2022 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 08/2020
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 11/2016
3	Immunoglobulin A (IgA)IBA 01/2022 - 06/2011
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 12/2013
3	AsbestosIBA 06/2021 - 01/2020
3	CrizotinibIBA 01/2021 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
3	Peptides (Polypeptides)IBA 12/2017 - 09/2012
3	CreatinineIBA 01/2017 - 01/2013
3	Ligases (Synthetase)IBA 08/2016 - 01/2013
3	Morphine (MS Contin)FDA LinkGeneric 07/2016 - 11/2013
3	Ethanol (Ethyl Alcohol)IBA 01/2016 - 01/2012

Therapy/Procedure

52	Therapeutics 02/2024 - 01/2002
29	Drug Therapy (Chemotherapy) 04/2024 - 08/2004
17	Immunotherapy 04/2024 - 09/2006
6	Radiotherapy 04/2024 - 11/2011
6	Cardiac Rehabilitation 02/2015 - 12/2004
5	Chemoradiotherapy 04/2024 - 10/2006
4	Stents 01/2024 - 07/2002
3	Traction 03/2024 - 01/2013
3	Continuous Positive Airway Pressure 09/2023 - 01/2023
3	Renal Dialysis (Hemodialysis) 10/2022 - 01/2015
3	Extracorporeal Membrane Oxygenation 04/2022 - 01/2021
3	Catheters 09/2015 - 01/2007
3	Percutaneous Coronary Intervention 05/2011 - 08/2004